Kaleido Biosciences, Inc. (KLDO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 9, 2026
Kaleido Biosciences Market Cap
Kaleido Biosciences has a market cap or net worth of $4.26 thousand as of October 9, 2026. It is the 52,042nd most valuable company in the world and the 8,076th biggest in the United States. Its market cap has increased by 9,811.63% in one year.
Market Cap
4.26K
Enterprise Value
n/a
Revenue
1.10M
Global Rank
Country Rank
#8,076 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 28, 2019, Kaleido Biosciences's market cap has decreased from 413.61M to 4.26K, a decrease of -100.00%. That is a compound annual growth rate of -77.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 4.26K | - |
| Dec 30, 2025 | 4.26K | 9,811.63% |
| Dec 31, 2024 | 43.00 | - |
| Dec 29, 2023 | 43.00 | -99.80% |
| Dec 30, 2022 | 21.31K | -99.98% |
| Dec 31, 2021 | 101.80M | -68.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Better Therapeutics | 5.45K |
| Aridis Pharmaceuticals | 5.33K |
| MultiCell Technologies | 5.00K |
| Arno Therapeutics | 4.98K |
| Affimed | 4.92K |
| ONE Bio | 4.19K |
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |